English
Procter & Gamble Health Q1 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,840.00
-148.80 (-2.48%)
-148.80 (-2.48%)Volume280.00
Updated: Fri 7 Nov, 2025 | 15:24:03
NSE
5,860.00-136.50 (-2.28%)
-136.50 (-2.28%)Volume25.67 K
Updated: Fri 7 Nov, 2025 | 15:29:43
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q1 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 205.14 | 262.98 | -21.99% |
| Depreciation/ Amortization | 5.77 | 7.16 | -19.41% |
| Operating Income | 108.27 | 20.90 | 418.04% |
| Net Income | 82.33 | 16.78 | 390.64% |
| Other Operating Expenses Total | 65.10 | 107.83 | -39.63% |
| Net Income Before Taxes | 111.40 | 22.83 | 387.95% |
| Total Revenue | 313.41 | 283.88 | 10.40% |
| Selling/ General/ Admin Expenses Total | 46.22 | 48.63 | -4.96% |
| Diluted Normalized EPS | 49.60 | 19.03 | 160.61% |